Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ASTELLAS PHARMA INC
6d ago ASTELLAS PHARMA : -Launch of Suglat Tablets, a Selective SGLT2 Inhibitor for Tre..
6d ago ASTELLAS PHARMA : US, Inc. to Pay $7.3 Million to Resolve False Claims Act Alleg..
7d ago ASTELLAS PHARMA : Launch of Suglat® Tablets, a Selective SGLT2 Inhibitor for Tre..
7d ago ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Yields New Data on HIV/AID..
7d ago ASTELLAS PHARMA : US Inc. to Pay $7.3 Million to Resolve False Claims Act Allega..
7d ago ASTELLAS PHARMA : Illinois-based Astellas to pay $7.3M settlement
7d ago ASTELLAS PHARMA : to pay $7.3M in drug-marketing settlement
04/15 ASTELLAS PHARMA : Named National Presenting Sponsor of the National Kidney Found..
04/09 Seattle Genetics Showcases Antibody-Drug Conjugate (ADC) Program and Technolo..
04/08 Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technol..
04/04 ASTELLAS PHARMA : Announces marketing authorisation application for xtandi (enza..
04/03 ASTELLAS PHARMA : ANNOUNCES MARKETING AUTHORISATION APPLICATION FOR XTANDI&trade..
03/31 ASTELLAS PHARMA : Establishment of Regenerative Medicine Unit
03/31 ASTELLAS PHARMA : NCCN Receives $2.2 Million in Research Funding from Astellas a..
03/27 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/27 ASTELLAS PHARMA INC : SPLIT: 5 of 1
03/26 ASTELLAS PHARMA : and Daiichi Sankyo Form Compound Library Sharing Partnership
03/25 ASTELLAS PHARMA : Announces Marketing Approval in Japan for XTANDI (enzalutamide..
03/24 ASTELLAS PHARMA : Announces Marketing Approval in Japan for XTANDI® (enzalutamid..
03/23 ASTELLAS PHARMA : and Medivation Submit sNDA for XTANDI (Enzalutamide) for Chemo..
03/21 ASTELLAS PHARMA : HHS Assigned Patent
03/20 ASTELLAS PHARMA : Pediatric Praziquantel Consortium awarded US$1.86 million GHIT..
03/19 ASTELLAS PHARMA : American Urological Association And Astellas Team Up To Secure..
03/18 ASTELLAS PHARMA : And medivation submit supplemental new drug application for xt..
03/18 ASTELLAS PHARMA : and Medivation Submit Supplemental New Drug Application for XT..
03/17 ASTELLAS PHARMA : Awarded Diversity Management Selection 100
03/16 ASTELLAS PHARMA : Awarded Diversity Management Selection 100 (pdf 196KB)
03/14 ASTELLAS PHARMA : American Urological Association and Astellas Team up to Secure..
03/05 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
03/03 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
03/03 ASTELLAS PHARMA INC : Basilea swaps its isavuconazole North American co-promote ..
02/28 ASTELLAS PHARMA INC : Astellas Announces Stock Split and Partial Amendment to th..
02/28 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
02/28 ASTELLAS PHARMA INC : AVEO and Astellas to Halt Collaboration & License Deal for..
02/28 ASTELLAS PHARMA INC : AVEO and Astellas Report Plans to End Worldwide Collaborat..
02/26 ASTELLAS PHARMA INC : Studies from Astellas Pharma, Inc. Yield New Information a..
02/26 ASTELLAS PHARMA INC : Agensys Assigned Patent
02/24 ASTELLAS PHARMA INC : OSI Pharmaceuticals Assigned Patent
02/20 ASTELLAS PHARMA INC : AVEO and Astellas Report Plans to End Worldwide Collaborat..
02/19 ASTELLAS PHARMA INC : Studies from Astellas Pharma, Inc. Have Provided New Data ..
02/19 ASTELLAS PHARMA INC : AVEO and Astellas to Halt Collaboration & License Deal for..
02/17 AVEO PHARMACEUTICALS, INC. : AVEO and Astellas to End Worldwide Collaboration & ..
02/12 ASTELLAS PHARMA INC : Findings from Astellas Pharma, Inc. Update Knowledge of Cl..
02/12 ASTELLAS PHARMA INC : Recent Research from Astellas Pharma, Inc. Highlight Findi..
02/09 AVEO GROUP : Aveo and Astellas to Discontinue Phase 2 Trial of Tivozanib in Brea..
02/05 ASTELLAS PHARMA INC : Reorganization of Astellas' Global Management Structure (p..
02/04 AVEO GROUP : Aveo and Astellas to Discontinue Phase 2 Trial of Tivozanib in Brea..
01/17 ASTELLAS PHARMA INC : Approval of Suglat® Tablets, a Selective SGLT2 Inhibitor f..
01/15 ASTELLAS PHARMA INC : Astellas Pharma: Launches Irribow OD Tablets in Japan for ..
01/15 ASTELLAS PHARMA INC : Astellas and UMN Announce Summary Results in Phase III Cli..
01/14 ASTELLAS PHARMA INC : Astellas Pharma: Launches Irribow® OD Tablets in Japan for..
01/08 ASTELLAS PHARMA INC : Study Findings from Astellas Pharma, Inc. Broaden Understa..
01/07 ASTELLAS PHARMA INC : ASTELLAS TO FORM STRATEGIC PARTNERSHIP WITH CLEARPATH TO B..
01/06 ASTELLAS PHARMA INC : ASTELLAS TO FORM STRATEGIC PARTNERSHIP WITH CLEARPATH TO B..
01/02 ASTELLAS PHARMA INC : Researchers from Astellas Pharma, Inc. Provide Details of ..
2013 ASTELLAS PHARMA INC : Astellas and IBL Concludes Co-Research Agreement Regarding..
2013 ASTELLAS PHARMA INC : Study Data from Astellas Pharma, Inc. Update Knowledge of ..
2013 ASTELLAS PHARMA INC : Approval of Additional Indication for Hypnosedative, Dormi..
2013 ASTELLAS PHARMA INC : ASTELLAS -Notice of Completion of Acquisition of Own Share..
2013 ASTELLAS PHARMA INC : Production Subsidiary Astellas Pharma Tech Concludes Defin..
2013 ASTELLAS PHARMA INC : Notice of Completion of Acquisition of Own Shares
2013 ASTELLAS PHARMA INC : FDA Grants Astellas Qualified Infectious Disease Product D..
2013 VICAL INCORPORATED : Astellas, Vical Initiate Phase 2 Trial of ASP0113 Vaccine i..
2013 ASTELLAS PHARMA INC : Japanese Astellas Pharma to open office in Serbia on Dec 1..
2013 ASTELLAS PHARMA INC : Astellas Concludes Agreement with Mitsui Fudosan Comprehen..
2013 ASTELLAS PHARMA INC : Research Data from Astellas Pharma, Inc. Update Understand..
2013 OSI Pharmaceuticals Assigned Patent
2013 ASTELLAS PHARMA INC : OSI Pharmaceuticals Assigned Patent
2013 Astellas named 'Company of the Year' at international SCRIP Awards 2013
2013 ASTELLAS PHARMA INC : Astellas named 'Company of the Year' at international SCRI..
2013 New Therapeutics Study Results Reported from Astellas Pharma, Inc.
2013 ASTELLAS PHARMA INC : New Therapeutics Study Results Reported from Astellas Phar..
2013 Nobel Laureate, Dr. Elizabeth H.Blackburn Joins Panel of The Astellas Innovat..
2013 ASTELLAS PHARMA INC : Nobel Laureate, Dr. Elizabeth H.Blackburn Joins Panel of T..
2013 ASTELLAS PHARMA INC : ASTELLAS -Support to Philippines Typhoon Haiyan and the Bo..
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF